These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4376661)

  • 21. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of protionamide on tuberculosis mycobacteria in vitro].
    Kalabukha AV; Klimenko MT
    Mikrobiol Zh; 1972; 34(6):778-82. PubMed ID: 4199956
    [No Abstract]   [Full Text] [Related]  

  • 23. [SYMPOSIUM: COUNTER-MEASURES IN INTRACTABLE PULMONARY TUBERCULOSIS].
    KITAMOTO O
    Kekkaku; 1963 Aug; 38():348-71. PubMed ID: 14046681
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 25. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 26. [Metabolism of carbohydrates and phosphates in the liver and lungs of animals treated with tuberculostatic drugs].
    Kharakter ZhZ
    Vopr Med Khim; 1967; 13(6):611-5. PubMed ID: 5628726
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 29. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
    WOLINSKY E
    Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093
    [No Abstract]   [Full Text] [Related]  

  • 30. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary drug resistance of mycobacteria tuberculosis in Taiwan.
    Wu YT
    Taiwan Yi Xue Hui Za Zhi; 1973 Mar; 72(3):135-42. PubMed ID: 4634133
    [No Abstract]   [Full Text] [Related]  

  • 32. [Identification of human chromosomes by chromomerization in vitro].
    Caratzali A; Roman IC; Cirnu-Georgian L; Geormaneanu C
    C R Acad Hebd Seances Acad Sci D; 1972 Feb; 274(8):1198-9. PubMed ID: 4624944
    [No Abstract]   [Full Text] [Related]  

  • 33. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
    FILLA E; COMENALE D; ROSSI F
    Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 35. [UROGENITAL TUBERCULOSIS: PATHOGENESIS, DIAGNOSIS AND THERAPY. SURVEY OF THE MOST IMPORTANT PUBLICATIONS OF THE LAST YEARS].
    ALBRECHT KF
    Urologe; 1964 Jan; 3():33-7. PubMed ID: 14160920
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tubercle; 1968 Mar; 49():Suppl:66-70. PubMed ID: 4173333
    [No Abstract]   [Full Text] [Related]  

  • 37. CHEMOTHERAPY OF TUBERCULOSIS.
    HORNE NW
    Biochem Clin; 1964; 4():207-15. PubMed ID: 14268921
    [No Abstract]   [Full Text] [Related]  

  • 38. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug reactions. 18. Cutaneous reactions to antituberculous drugs.
    Levantine A; Almeyda J
    Br J Dermatol; 1972 Jun; 86(6):651-5. PubMed ID: 4114691
    [No Abstract]   [Full Text] [Related]  

  • 40. Combinations of drugs against Mycobacterium leprae studied in mice.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.